Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Kunz

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Vaccine|March 12, 2003
TBE vaccination and the Austrian experienceChristian Kunz
International Journal of Medical Microbiology : IJMM|July 27, 2002
Vaccination against TBE in Austria: the success story continuesChristian Kunz
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 3, 2005
Current strategies for the development of peptide-based anti-cancer therapeuticsCorina Borghouts, Christian Kunz, Bernd Groner
Combinatorial Chemistry & High Throughput Screening|March 14, 2008
Peptide aptamer librariesCorina Borghouts, Christian Kunz, Bernd Groner
Expert Opinion on Biological Therapy|June 15, 2005
Peptide aptamers: recent developments for cancer therapyCorina Borghouts, Christian Kunz, Bernd Groner
Molecular Cancer Research : MCR|December 26, 2006
Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to TaxolChristian Kunz, Corina Borghouts, Claudia Buerger, et al.
Molecular Cancer Research : MCR|March 4, 2008
Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibitionCorina Borghouts, Christian Kunz, Natalia Delis, et al.
Experimental and Therapeutic Medicine|November 6, 2014
Late onset oral treatment with tranilast following large myocardial infarction has no beneficial effects on cardiac remodeling and mortality in ratsStefan Betge, Christian Kunz, Hans Figulla, et al.
Antibodies (Basel, Switzerland)|September 25, 2019
Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical SettingsNina Moeker, Solveig Peters, Robert Rauchenberger, et al.
Journal of Mammary Gland Biology and Neoplasia|September 2, 2006
The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibitionSylvane Desrivières, Christian Kunz, Itamar Barash, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Vaccine|March 12, 2003
TBE vaccination and the Austrian experienceChristian Kunz
International Journal of Medical Microbiology : IJMM|July 27, 2002
Vaccination against TBE in Austria: the success story continuesChristian Kunz
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 3, 2005
Current strategies for the development of peptide-based anti-cancer therapeuticsCorina Borghouts, Christian Kunz, Bernd Groner
Combinatorial Chemistry & High Throughput Screening|March 14, 2008
Peptide aptamer librariesCorina Borghouts, Christian Kunz, Bernd Groner
Expert Opinion on Biological Therapy|June 15, 2005
Peptide aptamers: recent developments for cancer therapyCorina Borghouts, Christian Kunz, Bernd Groner
Molecular Cancer Research : MCR|December 26, 2006
Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to TaxolChristian Kunz, Corina Borghouts, Claudia Buerger, et al.
Molecular Cancer Research : MCR|March 4, 2008
Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibitionCorina Borghouts, Christian Kunz, Natalia Delis, et al.
Experimental and Therapeutic Medicine|November 6, 2014
Late onset oral treatment with tranilast following large myocardial infarction has no beneficial effects on cardiac remodeling and mortality in ratsStefan Betge, Christian Kunz, Hans Figulla, et al.
Antibodies (Basel, Switzerland)|September 25, 2019
Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical SettingsNina Moeker, Solveig Peters, Robert Rauchenberger, et al.
Journal of Mammary Gland Biology and Neoplasia|September 2, 2006
The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibitionSylvane Desrivières, Christian Kunz, Itamar Barash, et al.
Pageof 3